Search

Your search keyword '"Rose, Esther"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Rose, Esther" Remove constraint Author: "Rose, Esther"
137 results on '"Rose, Esther"'

Search Results

4. Doing Coupledom : imagining, managing and performing relationality in contemporary wedding and civil partnership rituals

5. Beliefs about the causes of mental illness and attitudes towards seeking help : a study of British Jewry

9. The Experience of Receiving a Diagnosis and Treatment of ADHD in Adulthood: A Qualitative Study of Clinically Referred Patients Using Interpretative Phenomenological Analysis

14. Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

15. Daratumumab in transfusion‐dependent patients with low or intermediate‐ 1 risk myelodysplastic syndromes

16. Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

18. The Scepter and the Cilice: the Politics of Repentance in Sixteenth-Century France (1572-1610)

19. Treating cancer with PEG Intron

20. Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)

23. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro

25. Imetelstat Treatment Leads to Durable Transfusion Independence (TI) in RBC Transfusion-Dependent (TD), Non-Del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Who Are Lenalidomide (LEN) and HMA Naive

26. Imetelstat Is Effective Treatment for Patients with Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels

29. A phase III study of ibrutinib in combination with either bendamustine and rituximab (BR) or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously treated follicular lymphoma or marginal zone lymphoma.

30. Molecular Signatures of Cancer

31. A phase 3 study of ibrutinib in combination with either bendamustine and rituximab (BR) or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously treated follicular lymphoma or marginal zone lymphoma.

32. 837

33. Doing Coupledom: imagining, managing and performing relationality in contemporary wedding and civil partnership rituals

34. The POU Transcription Factor Drifter/Ventral veinless Regulates Expression of Drosophila Immune Defence Genes

35. Trio Relationships: Desire, Identity, and Power in Beauvoir's L'Invitee and Truffaut's Jules et Jim

36. NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics : a study based on mutation screening by pyrosequencing

37. Gene expression analysis of human epidermal keratinocytes after N-acetyl L-cysteine treatment demonstrates cell cycle arrest and increased differentiation

38. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro

45. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro

46. Gene Expression Analysis of Human Epidermal Keratinocytes after N-Acetyl L-Cysteine Treatment Demonstrates Cell Cycle Arrest and Increased Differentiation

48. Pancreatic Tuberculosis

49. Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome

50. Relapse of Hairy Cell Leukemia After 2-Chlorodeoxyadenosine: Long-Term Follow-Up of the Northwestern University Experience

Catalog

Books, media, physical & digital resources